Rare diseases
Investigational molecules
Locations
989 East Hillsdale Boulevard, 94404-2113, United States
Mirum Pharmaceuticals Inc. focuses on clinical research in cholestatic pruritus, including itching associated with primary biliary cholangitis and primary sclerosing cholangitis. The trials examine symptom control in liver-related itch conditions and the role of targeted therapies in reducing pruritus severity.
These studies place emphasis on patient-reported itch outcomes and on treatment options for chronic pruritus linked to cholestatic liver disease.
Mirum Pharmaceuticals Inc. runs clinical trials in conditions such as Hepatitis D, Fragile X syndrome, Alagille syndrome, Progressive familial intrahepatic cholestasis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Spain
AustriaAustria
BelgiumBelgium
BulgariaBelgiumBelgium
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
